ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.946
EU - Europa 7.926
AS - Asia 5.933
SA - Sud America 641
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 13
Totale 28.570
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.789
GB - Regno Unito 2.725
CN - Cina 2.163
IT - Italia 2.060
SG - Singapore 1.776
SE - Svezia 1.018
HK - Hong Kong 850
DE - Germania 559
BR - Brasile 537
UA - Ucraina 425
TR - Turchia 392
RU - Federazione Russa 265
FI - Finlandia 250
VN - Vietnam 233
KR - Corea 171
BG - Bulgaria 142
FR - Francia 142
IN - India 104
CA - Canada 89
NL - Olanda 81
LT - Lituania 51
AR - Argentina 47
MX - Messico 42
ZA - Sudafrica 42
IR - Iran 37
PL - Polonia 36
IE - Irlanda 35
ID - Indonesia 32
JP - Giappone 27
BE - Belgio 25
ES - Italia 24
EU - Europa 24
BD - Bangladesh 23
IQ - Iraq 19
CO - Colombia 18
PK - Pakistan 15
AE - Emirati Arabi Uniti 14
AT - Austria 14
EC - Ecuador 14
UZ - Uzbekistan 12
AU - Australia 11
CH - Svizzera 11
MA - Marocco 11
MY - Malesia 11
CZ - Repubblica Ceca 7
EG - Egitto 7
JO - Giordania 7
PA - Panama 7
VE - Venezuela 7
DZ - Algeria 6
IL - Israele 6
NO - Norvegia 6
SI - Slovenia 6
CL - Cile 5
GR - Grecia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
PE - Perù 5
PT - Portogallo 5
RS - Serbia 5
DO - Repubblica Dominicana 4
HN - Honduras 4
JM - Giamaica 4
KE - Kenya 4
PY - Paraguay 4
RO - Romania 4
SA - Arabia Saudita 4
AL - Albania 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
LV - Lettonia 3
MD - Moldavia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AZ - Azerbaigian 2
CU - Cuba 2
DK - Danimarca 2
KW - Kuwait 2
LB - Libano 2
MG - Madagascar 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UY - Uruguay 2
ZW - Zimbabwe 2
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
HU - Ungheria 1
Totale 28.551
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Santa Clara 1.539
Singapore 1.149
Fairfield 1.105
Ashburn 1.018
Woodbridge 1.011
Chandler 918
Hong Kong 832
Jacksonville 794
Hefei 787
Houston 671
Dearborn 572
Nyköping 514
Wilmington 493
Ann Arbor 449
Beijing 414
Seattle 382
Cambridge 374
London 336
Los Angeles 284
Chicago 275
Izmir 245
Milan 170
Rome 162
Seoul 161
New York 154
Princeton 147
Sofia 137
Eugene 135
San Diego 118
Dallas 117
Modena 116
Salt Lake City 116
Buffalo 110
Des Moines 105
Helsinki 95
Shanghai 94
Ho Chi Minh City 87
The Dalles 82
Moscow 80
Frankfurt am Main 75
Council Bluffs 74
Naples 71
Tampa 63
Munich 58
São Paulo 54
Elk Grove Village 52
San Jose 50
Bologna 42
Hanoi 42
Philadelphia 40
Columbus 39
Palermo 38
Nanjing 37
Florence 35
Bremen 34
Guangzhou 34
Boardman 31
Dublin 31
Redwood City 29
Warsaw 29
Kent 28
Sterling 28
Bari 27
Toronto 27
Verona 27
Turin 26
Montreal 25
Kunming 23
Tokyo 23
Brooklyn 22
Brussels 22
San Mateo 22
Augusta 21
Catania 21
Norwalk 21
Brescia 20
Ottawa 20
Boston 19
Detroit 19
Jakarta 19
Johannesburg 19
Lancaster 19
Parma 19
Miami 18
Orem 18
Phoenix 18
Turku 18
Atlanta 17
Falls Church 17
Zhengzhou 17
Chennai 16
Mexico City 16
Mumbai 16
Pittsburgh 16
Denver 14
Fremont 14
Grafing 14
Stockholm 14
Amsterdam 13
Totale 20.145
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.566
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 454
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 375
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 363
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 359
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 346
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 336
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 332
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 326
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 313
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 311
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 294
La clinica metabolica per il trattamento della lipodistrofia 291
Efficacy and safety of atazanavir in patients with end-stage liver disease. 287
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 283
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 280
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 278
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 276
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 268
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 264
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 264
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 263
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 263
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 255
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 254
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 254
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 250
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 250
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 247
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 247
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 246
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 243
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 242
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 240
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 235
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 234
Detectable HIV viral load is associated with metabolic syndrome 234
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 234
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 233
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 230
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 229
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 227
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 226
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 226
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 224
Age-related comorbidities in people living with HIV 224
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 223
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 217
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 217
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 216
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 213
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 212
Artropodi vettori di agenti infettivi 211
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 210
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 210
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 208
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 206
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 204
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 203
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 202
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 202
Prevalence of secondary causes of osteoporosis among HIV infected individuals 199
Severity of lipodystrophy is associated with decreased health-related quality of life 195
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 193
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 192
Body Image perception in HIV infected women with body fat redistribution. 189
Does lipodistrophy affect quality of life? 189
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 188
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 188
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 185
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 185
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 184
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 183
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 181
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 181
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 180
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 180
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 179
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 176
La trasmissione verticale di HIV nell’era della HAART 176
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 176
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 175
È possibile un counselling HIV su internet? 173
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 173
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 173
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 171
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 169
Validity of body image perception in women with HIV. 168
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 167
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 165
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 163
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 162
Erectile dysfunction does not mirror sub-clinical atherosclerosis in HIV infected males. 162
Body fat redistribution syndrome in HIV infected people is associated with good adherence to HAART 162
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 162
La casa alloggio: ospite, centro riabilitativo o entrambi? 161
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 160
Prevalence and risk factors of pubic lipomas in HIV-infected patients 155
Relapse of HIV-related buffalo hump after liposuction 155
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA 155
Totale 23.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.462 0 0 0 0 0 230 213 288 133 280 195 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.739 111 139 122 176 283 151 149 199 52 60 104 193
2024/20255.789 219 94 93 387 1.230 791 461 287 658 258 619 692
2025/20265.539 674 477 893 1.237 1.715 543 0 0 0 0 0 0
Totale 28.775